ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Bioorganic & Medicinal Chemistry
Volume 16, Issue 1, 1 January 2008, Pages 284-292
Nucleic Acid Modification for Fluroescence-Based Technologies
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (1578 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bmc.2007.09.036    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2007 Elsevier Ltd All rights reserved.

Discovery of novel α-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure

Hwangseo Parka, Corresponding Author Contact Information, E-mail The Corresponding Author, Kyo Yeol Hwangb, Kyung Hwan Ohb, Young Hoon Kimb, Jae Yeon Leeb and Keun Kimb, Corresponding Author Contact Information, E-mail The Corresponding Author

aDepartment of Bioscience and Biotechnology, Sejong University, 98 Kunja-Dong, Kwangjin-Ku, Seoul 143-747, Republic of Korea bDepartment of Bioscience and Biotechnology, The University of Suwon, San 2-2 Wau-ri, Bongdam-eup, Hwaseong-si, Gyeonggi-do 445-743, Republic of Korea

Received 20 August 2007; 
revised 17 September 2007; 
accepted 19 September 2007. 
Available online 22 September 2007.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Discovery of α-glucosidase inhibitors has been actively pursued with the aim to develop therapeutics for the treatment of diabetes and the other carbohydrate mediated diseases. We have been able to identify 13 novel α-glucosidase inhibitors by means of a computer-aided drug design protocol involving homology modeling of the target protein and the virtual screening with docking simulations under consideration of the effects of ligand solvation in the binding free energy function. Because the newly discovered inhibitors are structurally diverse and reveal a significant potency with IC50 values lower than 50 μM, all of them can be considered for further development by structure–activity relationship studies or de novo design methods. Structural features relevant to the interactions of the newly identified inhibitors with the active site residues of α-glucosidase are discussed in detail.

Graphical abstract


Keywords: α-glucosidase; Inhibitor; Virtual screening; Homology modeling; Enzyme assay; Docking; Diabets

Article Outline

1. Introduction
2. Results and discussion
2.1. Homology modeling of α-glucosidase
2.2. Virtual screening and in vitro α-glucosidase inhibition assay
2.3. Molecular modeling studies for the inhibitory mechanism
3. Conclusions
4. Experimental
4.1. Homology modeling of yeast α-glucosidase
4.2. Virtual screening of α-glucosidase inhibitors
4.3. In vitro α-glucosidase inhibition assay
Acknowledgements
References







Bioorganic & Medicinal Chemistry
Volume 16, Issue 1, 1 January 2008, Pages 284-292
Nucleic Acid Modification for Fluroescence-Based Technologies
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.